IS5590A - Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar - Google Patents

Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar

Info

Publication number: IS5590A
Authority: IS; Iceland
Prior art keywords: benzothiazinone; benzoxazinone; protease inhibitors; serine protease; serine
Prior art date: 1998-03-31

Application number

IS5590A

Other languages

English (en)

Inventor

Alan Berryman Kent

Michael Downing Dennis

Andrea Dudley Danette

John Edmunds Jeremy

Sourirajan Narasimhan Lakshmi

Taras Rapundalo Stephen

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-31

Filing date

2000-08-18

Publication date

2000-08-18

2000-08-18 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

2000-08-18 Publication of IS5590A publication Critical patent/IS5590A/is

Links

MJNPHLBKHKJDEF-UHFFFAOYSA-N 2h-1$l^{4},2-benzothiazine 1-oxide Chemical compound C1=CC=C2S(=O)NC=CC2=C1 MJNPHLBKHKJDEF-UHFFFAOYSA-N 0.000 title 1
HQQTZCPKNZVLFF-UHFFFAOYSA-N 4h-1,2-benzoxazin-3-one Chemical compound C1=CC=C2ONC(=O)CC2=C1 HQQTZCPKNZVLFF-UHFFFAOYSA-N 0.000 title 1
239000003001 serine protease inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

IS5590A 1998-03-31 2000-08-18 Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar IS5590A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8014298P	1998-03-31	1998-03-31
PCT/US1998/026708 WO1999050257A1 (en)	1998-03-31	1998-12-15	Benzoxazinones/benzothiazinones as serine protease inhibitors

Publications (1)

Publication Number	Publication Date
IS5590A true IS5590A (is)	2000-08-18

Family

ID=22155527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5590A IS5590A (is)	1998-03-31	2000-08-18	Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar

Country Status (15)

Country	Link
US (2)	US6509335B1 (is)
EP (1)	EP1068191A1 (is)
JP (1)	JP2002509925A (is)
KR (1)	KR20010042296A (is)
AU (1)	AU765223C (is)
BR (1)	BR9815784A (is)
CA (1)	CA2319551A1 (is)
HU (1)	HUP0101699A3 (is)
IL (1)	IL137656A0 (is)
IS (1)	IS5590A (is)
NO (1)	NO20004698L (is)
NZ (1)	NZ506985A (is)
PL (1)	PL343317A1 (is)
WO (1)	WO1999050257A1 (is)
ZA (1)	ZA992445B (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6291514B1 (en)	1998-02-09	2001-09-18	3-Dimensional Pharmaceuticals, Inc.	Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
SK11422001A3 (sk) *	1999-02-09	2002-04-04	3-Dimensional Pharmaceuticals Inc.	Heteroarylamidíny, metylamidíny a guanidíny ako inhibítory proteázy
FR2801885B1 (fr) *	1999-12-06	2002-01-11	Adir	Nouveaux derives (dihydro)benzoxaziniques et (dihydro) benzothiaziniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6777413B2 (en)	2000-02-01	2004-08-17	Millennium Pharmaceuticals, Inc.	2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa
WO2001057003A1 (en) *	2000-02-01	2001-08-09	Cor Therapeutics, Inc.	3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa
US7405158B2 (en)	2000-06-28	2008-07-29	Applied Materials, Inc.	Methods for depositing tungsten layers employing atomic layer deposition techniques
US6998408B2 (en)	2001-03-23	2006-02-14	Bristol-Myers Squibb Pharma Company	6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
WO2002080853A2 (en)	2001-04-09	2002-10-17	Bristol-Myers Squibb Company	Fused heterocyclic inhibitors of factor xa
US6794385B2 (en)	2001-08-08	2004-09-21	Pharmacia & Upjohn, S.P.A.	Benzoxazine derivatives useful as integrin receptor antagonists
US6750215B2 (en)	2001-08-08	2004-06-15	Pharmacia & Upjohn, S.P.A.	Substituted benzoxazines as integrin antagonists
US6916398B2 (en)	2001-10-26	2005-07-12	Applied Materials, Inc.	Gas delivery apparatus and method for atomic layer deposition
NZ533566A (en) *	2001-12-28	2007-03-30	Acadia Pharm Inc	Tetrahydroquinoline analogues as muscarinic agonists
EP1569912B1 (en)	2002-12-03	2015-04-29	Pharmacyclics, Inc.	2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
US6759298B2 (en) *	2002-06-24	2004-07-06	Micron Technology, Inc.	Methods of forming an array of flash field effect transistors and circuitry peripheral to such array
TWI289141B (en)	2003-03-11	2007-11-01	Hoffmann La Roche F. Ag.	Quinolinone derivatives and uses thereof
CA2540452A1 (en) *	2003-10-03	2005-04-14	Merck & Co., Inc.	Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
SI21658A (sl) *	2003-11-28	2005-06-30	Univerza V Ljubljani	Antitrombotične učinkovine z dualnim mehanizmom delovanja na osnovi 3,4-dihidro-2H-1,4-benzoksazinskega skeleta
AP2007003973A0 (en) *	2004-10-12	2007-07-30	Glenmark Pharmaceuticals Sa	Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation
US20080269204A1 (en) *	2004-11-01	2008-10-30	Tatyana Dyakonov	Compounds and Methods of Use Thereof
GB0515323D0 (en)	2005-07-26	2005-08-31	Electrophoretics Ltd	Mass labels
US20070197512A1 (en) *	2006-01-27	2007-08-23	Japan Tobacco Inc.	Carboxylic Acid Compounds and Use Thereof
WO2011024987A1 (ja) *	2009-08-31	2011-03-03	塩野義製薬株式会社	芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物
WO2012149567A1 (en) *	2011-04-29	2012-11-01	Mount Sinai School Of Medicine	Kinase inhibitors
JP6497808B2 (ja) *	2015-06-12	2019-04-10	アグロカネショウ株式会社	１，４−ベンゾチアジン−１，３−ジオン又は−１，１，３−トリオン誘導体およびこれを有効成分とする殺菌剤
EP4037687B1 (en) *	2019-10-01	2025-10-29	Molecular Skin Therapeutics, Inc.	Benzoxazinone compounds as klk5/7 dual inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3006916A (en) *		1961-10-31		W-dialkylaminoalkyl
US3124577A (en) *		1964-03-10		Hydroxyalkyl cyclic amlno
US3089872A (en) *	1961-03-31	1963-05-14	Olin Mathieson	Benzothiazine and benzothiazepine compounds
US3401166A (en)	1966-08-01	1968-09-10	Squibb & Sons Inc	Therapeutically active benzothiazines
GB1174626A (en) *	1967-05-23	1969-12-17	Bellon Labor Sa Roger	New Benzoxazine Derivatives
DE2044530A1 (de)	1970-02-04	1971-08-19	VEB Deutsches Hydrierwerk Rodleben, χ 4530 Roßlau	Verfahren zur Herstellung basisch substituierter 2,3 Dihydro 1,4 benzoxazm 3 one
US3725403A (en)	1970-10-20	1973-04-03	Squibb & Sons Inc	Benzothiazine derivatives
JPS5265280A (en) *	1975-11-26	1977-05-30	Squibb & Sons Inc	Benzoxadinones and their production
US4584300A (en) *	1983-02-07	1986-04-22	Santen Pharmaceutical Co., Ltd.	Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
JPS60166674A (ja)	1984-02-09	1985-08-29	Santen Pharmaceut Co Ltd	ベンゾチアジン誘導体
ATE71622T1 (de) *	1985-07-29	1992-02-15	Santen Pharmaceutical Co Ltd	Neue benzothiazinabkoemmlinge.
JPH01272524A (ja)	1988-04-21	1989-10-31	Japan Found Cancer Res	癌化学療法剤
JP2886570B2 (ja)	1989-09-29	1999-04-26	エーザイ株式会社	縮合ヘテロ環を有する化合物
US5652237A (en)	1994-09-09	1997-07-29	Warner-Lambert Company	2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
JP3118380B2 (ja)	1994-09-30	2000-12-18	三洋電機株式会社	光学レンズの焦点調節装置
JPH09227561A (ja)	1996-02-21	1997-09-02	Tanabe Seiyaku Co Ltd	キサンチン誘導体
CA2271116A1 (en) *	1996-11-13	1998-05-22	Gregory J. Wells	Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
EP0980362B1 (de)	1997-05-02	2006-08-16	Schering Aktiengesellschaft	Substituierte heterocyclen und deren verwendung in arzneimitteln

1998
- 1998-12-15 CA CA002319551A patent/CA2319551A1/en not_active Abandoned
- 1998-12-15 BR BR9815784-1A patent/BR9815784A/pt not_active Application Discontinuation
- 1998-12-15 US US09/622,265 patent/US6509335B1/en not_active Expired - Fee Related
- 1998-12-15 AU AU19183/99A patent/AU765223C/en not_active Expired - Fee Related
- 1998-12-15 EP EP98963965A patent/EP1068191A1/en not_active Withdrawn
- 1998-12-15 WO PCT/US1998/026708 patent/WO1999050257A1/en not_active Ceased
- 1998-12-15 IL IL13765698A patent/IL137656A0/xx unknown
- 1998-12-15 JP JP2000541161A patent/JP2002509925A/ja active Pending
- 1998-12-15 HU HU0101699A patent/HUP0101699A3/hu unknown
- 1998-12-15 KR KR1020007010839A patent/KR20010042296A/ko not_active Withdrawn
- 1998-12-15 NZ NZ506985A patent/NZ506985A/en unknown
- 1998-12-15 PL PL98343317A patent/PL343317A1/xx not_active Application Discontinuation
1999
- 1999-03-30 ZA ZA9902445A patent/ZA992445B/xx unknown
2000
- 2000-08-18 IS IS5590A patent/IS5590A/is unknown
- 2000-09-20 NO NO20004698A patent/NO20004698L/no unknown
2002
- 2002-11-12 US US10/292,771 patent/US20030187256A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL343317A1 (en)	2001-08-13
IL137656A0 (en)	2001-10-31
NO20004698D0 (no)	2000-09-20
AU1918399A (en)	1999-10-18
HUP0101699A3 (en)	2002-05-28
NO20004698L (no)	2000-09-20
US6509335B1 (en)	2003-01-21
HUP0101699A2 (hu)	2002-04-29
ZA992445B (en)	1999-10-01
NZ506985A (en)	2003-10-31
AU765223C (en)	2004-03-18
KR20010042296A (ko)	2001-05-25
JP2002509925A (ja)	2002-04-02
BR9815784A (pt)	2000-11-21
EP1068191A1 (en)	2001-01-17
CA2319551A1 (en)	1999-10-07
US20030187256A1 (en)	2003-10-02
WO1999050257A1 (en)	1999-10-07
AU765223B2 (en)	2003-09-11

Publication	Publication Date	Title
IS5590A (is)	2000-08-18	Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar
NO20004697L (no)	2000-09-20	Benzoksazinoner/benzotiazinoner som serin protease inhibitorer
NO20011966D0 (no)	2001-04-20	Serin-protease-inhibitor
NO20004696D0 (no)	2000-09-20	Kinoloner som serinproteaseinhibitorer
DE69823178D1 (de)	2004-05-19	Serine protease inhibitoren
DE69819349D1 (de)	2003-12-04	1-amino-7-isochinolin-derivate als serin protease inhibitoren
NO992734L (no)	1999-08-02	Serin-protease inhibitorer
NO20012980D0 (no)	2001-06-15	Proteaseinhibitorer
NO983688D0 (no)	1998-08-12	Serin-protease-inhibitorer
IL155202A0 (en)	2003-11-23	Biaryl compounds as serine protease inhibitors
EP1089752A4 (en)	2002-01-02	ALPHA-KETO OXADIAZOLE AS A SERINE PROTEASE INHIBITOR
ATE431358T1 (de)	2009-05-15	Peptidomimetika als protease inhibitoren
DE69730871D1 (de)	2004-10-28	Serine-protease-inhibitoren
ATE221080T1 (de)	2002-08-15	Serine-protease-inhibitoren
EP1179052A4 (en)	2004-12-15	SERINE PROTEASES
NO20011388L (no)	2001-05-16	Hydroksamat-inneholdende cystein- og serinproteasehemmere
AU6407701A (en)	2001-12-24	Serine protease inhibitors
EP1132473A4 (en)	2002-06-12	NEW SERINE PROTEASE BSSP6
EP1195163A4 (en)	2004-07-21	Serine protease inhibitors
EP1132477A4 (en)	2003-05-07	SERINE PROTEASE BSSP4
EP1206233A4 (en)	2004-04-14	Serine proteases
HK1038559A (en)	2002-03-22	Serine protease inhibitor